These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 11451679

  • 21. The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages.
    Alfano M, Pushkarsky T, Poli G, Bukrinsky M.
    J Virol; 2000 Sep; 74(18):8767-70. PubMed ID: 10954581
    [Abstract] [Full Text] [Related]

  • 22. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A, Hori T, Takaori-Kondo A, Morita R, Uchiyama T.
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Neuraminidase from a bacterial source enhances both HIV-1-mediated syncytium formation and the virus binding/entry process.
    Sun J, Barbeau B, Sato S, Tremblay MJ.
    Virology; 2001 May 25; 284(1):26-36. PubMed ID: 11352665
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effect of Sodium Lauryl Sulfate (SLS) on Primary Human Gingival Fibroblasts in an In Vitro Wound Healing Model.
    Chuang AH, Bordlemay J, Goodin JL, McPherson JC.
    Mil Med; 2019 Mar 01; 184(Suppl 1):97-101. PubMed ID: 30901402
    [Abstract] [Full Text] [Related]

  • 29. Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion.
    Gordon CJ, Muesing MA, Proudfoot AE, Power CA, Moore JP, Trkola A.
    J Virol; 1999 Jan 01; 73(1):684-94. PubMed ID: 9847374
    [Abstract] [Full Text] [Related]

  • 30. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells.
    Yu D, Wang W, Yoder A, Spear M, Wu Y.
    PLoS Pathog; 2009 Oct 01; 5(10):e1000633. PubMed ID: 19851458
    [Abstract] [Full Text] [Related]

  • 31. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
    Johnson JE, Schnell MJ, Buonocore L, Rose JK.
    J Virol; 1997 Jul 01; 71(7):5060-8. PubMed ID: 9188571
    [Abstract] [Full Text] [Related]

  • 32. Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus.
    Platt EJ, Durnin JP, Kabat D.
    J Virol; 2005 Apr 01; 79(7):4347-56. PubMed ID: 15767435
    [Abstract] [Full Text] [Related]

  • 33. Effects of all-trans retinoic acid and sodium lauryl sulphate on the permeability of human skin in vitro.
    Effendy I, Weltfriend S, Kwangsukstith C, Singh P, Maibach HI.
    Br J Dermatol; 1996 Sep 01; 135(3):428-32. PubMed ID: 8949438
    [Abstract] [Full Text] [Related]

  • 34. Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.
    Martinez ZS, Castro E, Seong CS, Cerón MR, Echegoyen L, Llano M.
    Antimicrob Agents Chemother; 2016 Oct 01; 60(10):5731-41. PubMed ID: 27431232
    [Abstract] [Full Text] [Related]

  • 35. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
    Takashima K, Miyake H, Furuta RA, Fujisawa JI, Iizawa Y, Kanzaki N, Shiraishi M, Okonogi K, Baba M.
    Antimicrob Agents Chemother; 2001 Dec 01; 45(12):3538-43. PubMed ID: 11709336
    [Abstract] [Full Text] [Related]

  • 36. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
    Foda M, Harada S, Maeda Y.
    Microbiol Immunol; 2001 Dec 01; 45(7):521-30. PubMed ID: 11529558
    [Abstract] [Full Text] [Related]

  • 37. Tumour necrosis factor-alpha stimulates HIV-1 replication in single-cycle infection of human term placental villi fragments in a time, viral dose and envelope dependent manner.
    Kfutwah AK, Mary JY, Nicola MA, Blaise-Boisseau S, Barré-Sinoussi F, Ayouba A, Menu E.
    Retrovirology; 2006 Jun 23; 3():36. PubMed ID: 16796744
    [Abstract] [Full Text] [Related]

  • 38. Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems.
    Luo T, Douglas JL, Livingston RL, Garcia JV.
    Virology; 1998 Feb 15; 241(2):224-33. PubMed ID: 9499797
    [Abstract] [Full Text] [Related]

  • 39. Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1.
    Ho SH, Martin F, Higginbottom A, Partridge LJ, Parthasarathy V, Moseley GW, Lopez P, Cheng-Mayer C, Monk PN.
    J Virol; 2006 Jul 15; 80(13):6487-96. PubMed ID: 16775336
    [Abstract] [Full Text] [Related]

  • 40. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein.
    Kowalski M, Bergeron L, Dorfman T, Haseltine W, Sodroski J.
    J Virol; 1991 Jan 15; 65(1):281-91. PubMed ID: 1702159
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.